One solution might be to employ the use of
expensive, high tech detectors that can identify the tell-tale molecules
released by lung membranes during the early stages of infection.
Eventually, experts predict that
detectors weighing no more than two kilograms costing less than $5000
will come on the market and such devices will help doctors in their
diagnosis. They can also be set up around the city to provide early
warning of an airborne pathogen. Other developments include using
gadgets such as microscopic electronic chips containing live nerve cells
that can warn of the presence of bacterial toxins or viruses.
Like a canary in a coal mine, these
chips will let off a steady stream of "chatter" until
something kills them. The only drawback is that this "canary in a
chip" is unable to detect specific pathogens. Other devices in the
pipeline include a fibre optic tube lined with antibodies attached to
photon emitting molecules. When toxins or bacteria stimulate these
molecules, they light up.
Devices based on antibodies aren’t
very useful. First of all, you need the correct antibody. Not easy once
you realize the huge number of pathogens (and their corresponding
mutations) you need to include. Secondly, most
pathogens are able to change their surface proteins from time to time.
For example, a stronger protein
coat might enable that protein to live longer in air, thus making it
airborne. Even then, even the correct antibodies can only determine the
nature of the particle’s surface. Germs can be protected by surface
gels or biological polymer "jackets" to foil antibodies. Even
normally harmless bacteria can be suitably altered modified to carry
nasty genes.
To combat this threat,
researchers are trying to harness the potential of RNA analysis. Unlike
DNA, RNA is abundant in cells and need not be amplified to be
identified. This saves time, and money. Messenger RNA particles reveal
not only the nature of the microorganism but also the type of toxin it
is producing.